Skripsi
EFEKTIVITAS PENAMBAHAN SUPLEMEN VITAMIN D TERHADAP KADAR BRAIN DERIVED NEUROTROPHIC FACTOR DAN MASSA OTOT, KEKUATAN OTOT SERTA PERFORMA FISIK PADA PASIEN USIA LANJUT DI INSTALASI RAWAT JALAN GERIATRI RSMH PALEMBANG
Background: The aging process is closely associated with a decline in muscle mass and function as well as a decrease in neurotrophin levels, such as Brain-Derived Neurotrophic Factor (BDNF). Vitamin D deficiency is prevalent among the elderly and is thought to play a role in the pathophysiology of musculoskeletal decline. This study aims to evaluate the effectiveness of Vitamin D supplementation on BDNF levels, muscle mass, muscle strength, and physical performance in geriatric patients. Methods: This study was a double-blind randomized clinical trial involving 30 geriatric patients at Dr. Mohammad Hoesin General Hospital, Palembang. Subjects were randomized into a treatment group receiving Vitamin D 5000 IU/day (n=15) and a placebo group (n=15) for 12 weeks. Parameters measured included serum 25(OH)D levels, BDNF levels, muscle mass (via Bioelectrical Impedance Analysis), handgrip strength, and physical performance using the Timed Up and Go Test (TUG). Results: Supplementation with 5000 IU of Vitamin D significantly increased serum 25(OH)D levels (p < 0.001). There was a positive correlation between the increase in Vitamin D levels and the maintenance of serum BDNF levels. The intervention group showed significant improvements in muscle strength and physical performance scores (p < 0.05) compared to the placebo group. Although muscle mass remained relatively stable, the improvement in physical functional quality was more pronounced in the supplemented group. Multivariate analysis indicated that baseline Vitamin D status and comorbidity scores influenced clinical outcomes. Conclusion: Vitamin D supplementation of 5000 IU is effective in preventing the decline of BDNF levels and improving muscle strength and physical performance in elderly patients. This intervention can be considered as part of comprehensive management to prevent sarcopenia in the geriatric population.
No other version available